Albert Seymour, Chief Scientific Officer at Homology Medicines, Inc. (FIXX), sold 30,000 shares at $12.05 ($362K) on 2021-01-07, disclosed to the SEC on 2021-01-08.
Open-market sale of $362k FIXX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.06 | 9,897 | $119K | 33.0% |
| 2 | $12.06 | 9,897 | $119K | 33.0% |
| 3 | $12.05 | 5,103 | $61K | 17.0% |
| 4 | $12.05 | 5,103 | $61K | 17.0% |
| Total | $12.06 avg | 30,000 | $362K | 100% |
| Filing → |
| FIXX | SELL | 2022-01-12 | $6K | — | Filing → |
| FIXX | SELL | 2021-01-07 | $114K | — | Filing → |
| FIXX | SELL | 2020-01-03 | $374K | — | Filing → |